Metformin Is One of the Common Non-Insulin Therapies for Diabetes Treatment
Non-Insulin Therapies for Diabetes Market |
Metformin is a type of non-insulin therapy
for diabetes. It is often used to treat prediabetes. Other medications may
include metformin, Glucophage, and glucagon. These medicines all work in
different ways to help control blood glucose levels and reduce the need for
insulin. They can also help the body better use sugar. Some drugs work by
reducing the amount of glucose that enters the blood, and others work by
slowing down the body's digestion of sugars.
There are several different
types of non-insulin therapies for diabetes, but the majority are used
in type 2 patients. These medications are typically taken orally and work with
a number of different systems to lower blood sugar levels. Some of the
medications decrease hepatic glucose yield, inhibit starch assimilation in the
small intestine, and decrease post-supper sugar. Others can affect the
pancreas, causing a slight increase in insulin production.
Fortunately, there are a variety of
non-insulin drugs for diabetes that are effective at controlling blood sugar
levels and can also be taken without a prescription. These medications are
usually injected into the body and help regulate blood sugar. However, patients
should consider that these treatments can also have side effects. These
medicines can cause nausea, indigestion, and dizziness.
Type 2 diabetes is a serious condition that
requires the use of insulin to control blood sugar levels. While insulin
therapy is usually the last resort, there are other non-insulin drugs that can
be used alongside insulin. These medications can help control blood glucose
levels, decrease insulin needs, or improve the body's ability to process sugar.
Recently, Novo Nordisk has launched a GLP-1 injectable
diabetes drug in tablet form. It is billed as an oral drug that promises to not
just help diabetes patients deal with the ailment but also perhaps offer other
benefits such as weight reduction and reduced cardiac risk
Comments
Post a Comment